AstraZeneca, Germany and over-65s: How to interpret confusing vaccine data

Study reveals wide health disparity between different ethinc groups in England
29 January 2021
Cervical cancer screening rates dropped during stay-at-home order
29 January 2021

AstraZeneca, Germany and over-65s: How to interpret confusing vaccine data

Germany has recently announced that it will not offer the AstraZeneca COVID-19 jab to over-65s due to insufficient data about its efficacy in that age group.

Comments are closed.